1. Home
  2. RYAM vs IMRX Comparison

RYAM vs IMRX Comparison

Compare RYAM & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYAM
  • IMRX
  • Stock Information
  • Founded
  • RYAM 1926
  • IMRX 2008
  • Country
  • RYAM United States
  • IMRX United States
  • Employees
  • RYAM N/A
  • IMRX N/A
  • Industry
  • RYAM Paper
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYAM Basic Materials
  • IMRX Health Care
  • Exchange
  • RYAM Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • RYAM 255.7M
  • IMRX 232.9M
  • IPO Year
  • RYAM N/A
  • IMRX 2021
  • Fundamental
  • Price
  • RYAM $6.96
  • IMRX $8.07
  • Analyst Decision
  • RYAM Buy
  • IMRX Strong Buy
  • Analyst Count
  • RYAM 1
  • IMRX 4
  • Target Price
  • RYAM $6.00
  • IMRX $13.75
  • AVG Volume (30 Days)
  • RYAM 653.6K
  • IMRX 1.3M
  • Earning Date
  • RYAM 11-04-2025
  • IMRX 11-12-2025
  • Dividend Yield
  • RYAM N/A
  • IMRX N/A
  • EPS Growth
  • RYAM N/A
  • IMRX N/A
  • EPS
  • RYAM N/A
  • IMRX N/A
  • Revenue
  • RYAM $1,519,622,000.00
  • IMRX N/A
  • Revenue This Year
  • RYAM N/A
  • IMRX N/A
  • Revenue Next Year
  • RYAM $4.65
  • IMRX N/A
  • P/E Ratio
  • RYAM N/A
  • IMRX N/A
  • Revenue Growth
  • RYAM N/A
  • IMRX N/A
  • 52 Week Low
  • RYAM $3.35
  • IMRX $1.10
  • 52 Week High
  • RYAM $10.28
  • IMRX $9.37
  • Technical
  • Relative Strength Index (RSI)
  • RYAM 85.57
  • IMRX 69.91
  • Support Level
  • RYAM $5.50
  • IMRX $7.82
  • Resistance Level
  • RYAM $6.07
  • IMRX $8.85
  • Average True Range (ATR)
  • RYAM 0.27
  • IMRX 0.75
  • MACD
  • RYAM 0.08
  • IMRX 0.19
  • Stochastic Oscillator
  • RYAM 93.79
  • IMRX 69.91

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: